Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
PyratineA1
- Development stage
- Unknown
- Lead developer
- Pyratine
- Modality
- Small Molecules
- Administration
- Topical
01
Overview
PyratineA1 is a topical consumer skincare product developed by Pyratine LLC for the management of inflammatory skin conditions such as rosacea, eczema, and atopic dermatitis. The formulation contains 0.110% furfuryl tetrahydropyranyl adenine, a plant-derived cytokinin and derivative of kinetin. It is designed to reduce facial redness, inflammatory lesions, and hyperpigmentation while improving skin barrier function and moisture retention. Marketed as a cosmetic rather than a pharmaceutical drug, it utilizes cytokinin chemistry to purportedly slow cellular aging processes and soothe sensitive or irritated skin. The product represents an evolution of the company's earlier PyratineXR and Pyratine-6 lines, featuring a lighter texture while maintaining the same active technology.
- Brand names
- PyratineA1PyratineA-1PyratineA 1PyratineXRPyratine-6Pyratine6Pyratine 6
- Other names
- furfuryl tetrahydropyranyl adeninePyratine A1
Beyond the preview
Go deeper on PyratineA1.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on PyratineA1.